AstraZeneca, Pfizer and other multinational drug companies have spent a record amount on medicines developed by Chinese biotechs this year
AstraZeneca has signed the most licensing deals with Chinese biotechs, at least $13.6bn of licensing deals with five companies so far this year
US pharmaceutical companies AbbVie, Merck, Pfizer and Regeneron also signed multibillion-dollar licensing deals in the first half of 2025.
Pfizer signed the biggest Chinese licensing deal this year, a $6bn agreement with 3Sbio to develop a cancer drug
All this [pharmaceutical] money has gone into China because China has invested in their industry while the US government has not,” Axelsen said.
Put us behind the rest of the world so that we would be forced to play catch-up by investing a bunch of money, and then have the government funnel that money into private corporations owned by tech billionaires